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MBoC | ARTICLE
Activating transcription factor 3 promotes loss 
of the acinar cell phenotype in response to 
cerulein-induced pancreatitis in mice
ABSTRACT Pancreatitis is a debilitating disease of the exocrine pancreas that, under chronic 
conditions, is a major susceptibility factor for pancreatic ductal adenocarcinoma (PDAC). 
Although down-regulation of genes that promote the mature acinar cell fate is required to 
reduce injury associated with pancreatitis, the factors that promote this repression are 
unknown. Activating transcription factor 3 (ATF3) is a key mediator of the unfolded protein 
response, a pathway rapidly activated during pancreatic insult. Using chromatin immunopre-
cipitation followed by next-generation sequencing, we show that ATF3 is bound to the tran-
scriptional regulatory regions of >30% of differentially expressed genes during the initiation 
of pancreatitis. Of importance, ATF3-dependent regulation of these genes was observed only 
upon induction of pancreatitis, with pathways involved in inflammation, acinar cell differen-
tiation, and cell junctions being specifically targeted. Characterizing expression of transcrip-
tion factors that affect acinar cell differentiation suggested that acinar cells lacking ATF3 
maintain a mature cell phenotype during pancreatitis, a finding supported by maintenance of 
junctional proteins and polarity markers. As a result, Atf3–/– pancreatic tissue displayed 
increased tissue damage and inflammatory cell infiltration at early time points during injury 
but, at later time points, showed reduced acinar-to–duct cell metaplasia. Thus our results 
reveal a critical role for ATF3 as a key regulator of the acinar cell transcriptional response dur-
ing injury and may provide a link between chronic pancreatitis and PDAC.
INTRODUCTION
Pancreatitis involves fibrosis and inflammation of the exocrine pan-
creas, often the result of exposure to acute or chronic environmental 
stresses, including alcohol consumption, gall stone obstruction of 
the pancreatic duct, or hypersensitivity to pharmaceutical drugs 
(Yadav and Lowenfels, 2013; Roberts, 2015). Chronic and hereditary 
forms of pancreatitis are a significant susceptibility factor for pancre-
atic ductal adenocarcinoma (PDAC; Logsdon and Ji, 2009; Yadav 
and Lowenfels, 2013), likely due to prolonged loss of the acinar cell 
phenotype in these conditions (Grady et al., 1998; Shi et al., 2013). 
The initiating events in all forms of pancreatitis include intracellular 
activation of digestive enzymes (Grady et al., 1998), deregulation of 
Ca2+ homeostasis (Krüger et al., 2000), loss of acinar cell maturation 
factors (von Figura et al., 2014), and activation of interstitial fibro-
blasts to stellate cells (Erkan et al., 2012). The degree of activation 
of these events determines the severity of pancreatitis. Therefore 
understanding how they are transcriptionally regulated is of 
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decreases the severity of injury (Krah et al., 2015; Martinelli et al., 
2015).
The goal of this study was to characterize the transcriptional tar-
gets and roles of ATF3 in the cerulein-induced pancreatitis (CIP) 
model. Global chromatin immunoprecipitation sequencing (ChIP-
seq) and RNA-sequencing (RNA-seq) suggest that ATF3 is enriched 
at more than one-third of all genes differentially expressed within 4 
h of initiating CIP. Examination of differential RNA expression in 
mice carrying a targeted deletion of Atf3 (Atf3–/–) confirms a role for 
ATF3 in mediating the UPR and affecting cell differentiation. Acinar 
cells in Atf3–/– mice maintain their mature phenotype during CIP, 
correlating to increased tissue injury. However, Atf3–/– mice also 
show decreased acinar-to-ductal metaplasia (ADM) during the re-
generative phases of CIP. These results suggest that ATF3 reduces 
the initial severity of pancreatic injury but leads to increased poten-
tial for events that promote PDAC.
RESULTS
Previous studies examining gene expression during pancreatitis 
provided only limited information on ATF3 (Kubisch et al., 2006; 
Kowalik et al., 2007). Therefore we characterized temporal and 
spatial ATF3 expression in acute and recurrent models of CIP. Dur-
ing acute CIP, Atf3 was significantly increased as early as 1 h after 
initial cerulein injections, peaking 4 h into CIP (48-fold higher than 
Atf3 levels in control pancreatic tissue; Figure 1A). There was a 
transient decrease in Atf3 expression 32 h into CIP, but by 72 h, 
Atf3 levels remained significantly higher (10-fold) than in saline-
treated pancreatic tissue. Western blot analysis confirmed in-
creased ATF3 accumulation (Figure 1B), and immunofluorescence 
(IF) showed that ATF3 accumulation is specific to acinar cells 
(Figure 1C). Western blot analysis identified two bands for ATF3 
(Figure 1C), and previous work suggested two isoforms exist for 
ATF3 that may have opposite roles in gene expression (i.e., activat-
ing vs. repressing functions; Chen et al., 1994). However, we cannot 
exclude the possibility that posttranslational modification of ATF3 
accounts for bands of different mobility. Similar increases in ex-
pression were observed for other UPR mediators, including spliced 
(s) XBP1 (Figure 1B and Supplemental Figure S1) and Atf4 (unpub-
lished data), consistent with previous studies demonstrating sig-
nificant increases in Xbp1 splicing after pancreatic insult (Kubisch 
et al., 2006; Kubisch and Logsdon, 2007; Lugea et al., 2011). How-
ever, unlike ATF3, sXBP1 and ATF4 accumulation was observed in 
pancreatic tissue before CIP induction. Recurrent CIP treatment 
(Supplemental Figure S2) led to similar transient increases in ATF3 
expression. ATF3 accumulation was apparent at the cerulein injec-
tion endpoint (day 0; Figure 1D). Three days after CIP treatment, 
ATF3 accumulation was still readily apparent, but by 28 d after 
cessation of CIP treatment, only small pockets of ATF3+ cells were 
observed (Figure 1E).
Because ATF3 is a transcription factor, we hypothesized that it 
would play an important role in determining gene expression pat-
terns in response to CIP treatment. To delineate the targets of ATF3 
during CIP, we performed ChIP-seq and RNA-seq for ATF3 on 
whole pancreatic tissue at a time consistent with peak ATF3 levels 
(i.e., 4 h into CIP). Because IF indicated acinar-specific localization of 
ATF3, we were not concerned about the inclusion of non–acinar cell 
populations. Peak calling identified 12,535 peaks of ATF3 enrich-
ment over input controls (Table 1). This number of peaks is signifi-
cantly lower (∼40%) than reported in previous studies on global 
ATF3 enrichment (Zhao et al., 2016) and could reflect the nature of 
the starting source, as we used whole tissue that expressed ATF3 for 
only 4 h versus cell cultures that constitutively expressed ATF3. 
significant interest. In particular, several studies have shown rapid 
activation of the unfolded protein response (UPR) within minutes of 
initiating pancreatitis in rodent models (Kubisch et al., 2006; Kowalik 
et al., 2007).
The UPR and endoplasmic reticulum (ER) stress pathways have a 
dual role in cell physiology and pathology. The UPR is considered to 
be an immediate response to cell stress, typically activated by the 
presence of misfolded proteins (Wu and Kaufman, 2006; Ron and 
Walter, 2007). In this situation, the UPR works to mitigate damage 
caused by acute stress through reduction of protein load. Transla-
tion of new protein is significantly reduced (Ron and Walter, 2007), 
ubiquitination and degradation of existing protein is increased 
(Bernales, 2006), and the transcription profile is altered to promote 
the expression of proteins involved in these events (Bernales, 2006). 
However, chronic or recurrent activation of the UPR is detrimental, 
promoting cell apoptosis (Bernales, 2006) or alterations in gene ex-
pression that can enhance disease (Bernales, 2006; Kubisch et al., 
2006). Therefore tight regulation of the UPR is required for an 
appropriate response to injury.
The UPR consists of three main signaling pathways that exhibit 
significant cross-talk (Bernales, 2006; Maas and Diehl, 2015). The 
PKR-like ER kinase (PERK) pathway is activated after dissociation of 
BiP/GRP78, leading to autoactivation, dimerization, and phosphory-
lation of eIF2α, a key member of the translation initiation complex 
(Harding et al., 2000; Ron et al., 2000). Phosphorylation of eIF2α 
reduces its ability to interact with this complex, promoting a global 
reduction in mRNA translation (Zhang et al., 2002). Activating tran-
scription factor 4 (ATF4) is a direct downstream mediator of PERK 
(Bernales, 2006). The inositol-requiring enzyme 1 (IRE1) pathway is 
activated in a similar manner to PERK but directly targets and pro-
motes splicing of X-box binding protein 1 (Xbp1) mRNA, leading to 
the expression of a potent transcription factor (sXBP1; Calfon et al., 
2002; Lee et al., 2002), which promotes increased expression of nu-
merous chaperones leading to protein degradation (Maas and 
Diehl, 2015). ATF6 is the third pathway to be activated and is 
believed to provide an adaptive response to long-term cell stress 
(Bernales, 2006; Wu et al., 2007). Targeted deletion of Ire1, Perk, 
Atf4, or Xbp1 within the pancreas leads to altered morphology, 
function, and cell survival, underscoring their important physiologi-
cal relevance to acinar cell homeostasis (Zhang et al., 2002; Iida 
et al., 2007; Iwawaki et al., 2010; Hess et al., 2011).
The UPR also plays a role in the pathological response to pancre-
atic injury. During pancreatitis, the UPR is rapidly activated (Kubisch 
et al., 2006; Kowalik et al., 2007), suggesting a protective mecha-
nism of action. However, prolonged periods of both increased and 
decreased UPR levels have been linked to more severe pancreatic 
injury (Alahari et al., 2011; Lugea et al., 2011; Sah et al., 2014). A 
better understanding of UPR mediators that are activated by pan-
creatic injury will provide clarity on these conflicting findings.
Activating transcription factor 3 (ATF3) is a mediator of the PERK/
ATF4 pathway (Jiang et al., 2004) that, within the pancreas, is ex-
pressed only after pancreatitis is initiated (Kowalik et al., 2007). 
Rapid increases in ATF3 expression have been identified in several 
models of experimental pancreatitis (Allen-Jennings et al., 2001; 
Kowalik et al., 2007), yet it is unclear how this increase affects the 
pancreatic response to injury. ATF3 can function as a transcriptional 
repressor, targeting pancreatic and duodenal homeobox 1 (PDX1) 
expression and function during β-cell stress (Jang, 2011; Kim et al., 
2011). However, a common event in acinar cells during pancreatitis 
is the repression of factors that stabilize a mature phenotype, 
including Mist1 (Kowalik et al., 2007), Nr5a2 (Masui et al., 2010), and 
Rbpjl (von Figura et al., 2014), and this loss of acinar cell maturity 
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unrelated cell type by Zhao et al. (2016), 
confirming the validity of our ChIP-seq data 
set. No other motifs were found in a signifi-
cant number of ATF3 enrichment sites. 
These findings suggest a significant role for 
ATF3 in regulating the acinar cell transcrip-
tome during the immediate response to 
pancreatitis.
Gene Ontology (GO) analysis was per-
formed using the 3411 genes enriched for 
ATF3 and identified a number of broad GO 
categories, including regulation of intracel-
lular signal transduction, protein phosphory-
lation, and cell junction organization. GO 
analysis also indicated that the response to 
unfolded proteins was directly targeted by 
ATF3 (highlighted in blue; Supplemental 
Figure S3A and Supplemental Table S2). 
Several additional GO terms, including the 
response to topologically incorrect proteins 
and response to ER stress, supported the 
involvement of ATF3 in responding to cell 
stress (highlighted in red; Supplemental 
Figure S3A). GO analysis also revealed sig-
nificant ATF3 enrichment at gene networks 
involved in catabolic processes, cell junction 
assembly, and cell organization. The same 
gene set was used for PANTHER and KEGG 
pathway analysis (Supplemental Figure S3, 
B and C, and Supplemental Table S3). 
Genes enriched for ATF3 were identified in 
pathways known to be involved in cerulein-
induced pancreatic injury (cholecystokinin 
[CCK] signaling [Kowalik et al., 2007] and 
epidermal growth factor [EGF] receptor and 
mitogen-activated protein kinase signaling 
[Ardito et al., 2012]) and pancreatic cancer 
(Shi et al., 2013), as well as those involved in 
endocytosis, pancreatic cell differentiation, 
including Notch (Gomez et al., 2004) and 
Wnt signaling (Morris et al., 2010), tight 
junctions, and adherens junctions (Collares-
Buzato et al., 2004). Several of these pathways were also identified 
by Zhao et al (2016; Supplemental Tables S2 and S9).
To determine whether ATF3 enrichment corresponded to 
changes in gene expression after CIP treatment, we cross-refer-
enced the ChIP-seq data to RNA-seq, comparing gene expression 
in pancreatic tissue from wild-type mice treated for 4 h with cerulein 
or saline (Figure 2D and Supplemental Figure S4A). Based on RNA-
seq analysis alone, 3482 genes were differentially expressed 4 h into 
cerulein treatment (adjusted p < 0.01). Of these genes, 2263 were 
significantly increased and 1219 genes were significantly decreased 
(Table 1 and Supplemental Figure S4A). In total, >34% (1203) of 
genes differentially expressed during CIP were also enriched for 
ATF3 at this 4-h time point, confirming an important role for ATF3 in 
mediating acinar cell transcription during CIP. Although ATF3 has 
been described as a transcriptional repressor, the presence of ATF3 
at a gene did not exclusively correlate with decreased gene expres-
sion during CIP (Figure 2D). Of all genes with significantly increased 
expression during CIP, 41.2% are enriched for ATF3, and 22.1% of 
all genes with significantly decreased expression are enriched for 
ATF3. Similarly, no correlation to gene expression (i.e., increased or 
Zhao et al. (2016) identified 19.4% of ATF3 enrichment peaks in 
promoter regions, whereas our study identified 45.9% of all ATF3 
enrichment sites (5759) localized within promoters. This discrepancy 
could reflect the increased number of peaks in intragenic regions 
obtained in the previous study but also may reflect differences in 
defining promoter regions. Zhao et al. (2016) used regions ±2 kb 
surrounding the transcription start site (TSS) and identified >6000 
genes enriched for ATF3. We used ±5 kb surrounding TSSs, which 
included 2880 sites within the 5’ UTR and coding sequence (CDS; 
Figure 2, A and B). Using this close association (±5 kb from a known 
TSS), we identified ATF3 enrichment sites associated with 3411 
genes within 4 h of inducing CIP (Table 1). Of importance, both 
studies showed that the majority of ATF3 enrichment sites within 
promoter regions appear near the TSS, indicating a close associa-
tion between ATF3 and annotated gene start sites.
Motif analysis identified three consensus sites that appear in a 
significant number of ATF3-enriched regions. These motifs are 
found in 44% (5’ TGAG/CTCA 3’), 31% (5’ TGAT/CG/CTCA 3’), and 
18% (5’ TGATGC/TA/CA 3’) of all ATF3-enriched sites (Figure 2C) 
and have been reported as target sites for ATF3 enrichment in an 
FIGURE 1: ATF3 is elevated during acute and recurrent experimentally induced pancreatitis. 
(A) qRT-PCR analysis for Atf3 after saline or cerulein treatment 4–72 h after initiating treatment. 
*p < 0.05; n values are indicated on the graph. (B) Representative Western blot analysis for 
ATF3, spliced (s) XBP1, or total (t) eIF2α (as a loading control) 1–8 h after initial saline (Sal) or 
cerulein (CIP) treatment. (C) IF analysis for ATF3 at 4 h into CIP shows expression exclusively in 
acinar tissue. I, islet. Bar, 60 μm. IF for ATF3 in recurrent CIP (D) 1 d, 3 d, or (E) 28 d after 
cessation of treatment with cerulein or saline. Boxed areas are shown at higher magnification. In 
all instances, sections are counterstained with DAPI (blue). Bar, 36 μm.
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genes were altered in cerulein-treated Atf3–/– mice that were not 
changed in WT mice after CIP. This suggests that the significant al-
terations in CIP gene expression profiles in the absence of ATF3 
may be due to activating and repressive effects of ATF3. Of the 
1293 genes differentially expressed in only WT tissue, 298 (23%) 
were identified as enriched for ATF3 based on ChIP-seq analysis, 
suggesting both direct and indirect transcriptional effects of ATF3 
on the acinar cell response to CIP.
GO analysis of biological processes associated with differentially 
expressed genes of CIP-treated WT and Atf3–/– mice confirmed 
differences in the way WT and Atf3–/– mice responded to CIP (Sup-
plemental Table S7) and suggested that the response to stress, 
posttranscriptional regulation of gene expression, regulation of 
apoptosis signaling, and cell junction organization may all be af-
fected by the loss of ATF3. Analysis of both KEGG and PANTHER 
pathways (Supplemental Figure S4, A and B, and Supplemental 
Tables S8 and S9) showed marked differences between WT and 
Atf3–/– tissue in the response to CIP—specifically, in pathways linked 
to inflammation, EGF signaling, adherens junctions, and Wnt signal-
ing. Of interest, generating a heat map for all genes differentially 
expressed between saline and cerulein treatments in either WT or 
Atf3–/– mice (Figure 3C; 3914 genes in total based on an adjusted 
p < 0.01) revealed gene clusters in which expression was increased 
or decreased after CIP. Whereas some differences between geno-
types could be identified based on expression changes, more-
defined clusters of genes were not readily apparent. Therefore we 
focused on genes that show differential expression specific between 
cerulein-treated WT and Atf3–/– mice. Using an adjusted p < 0.01, 
we identified only 41 differentially expressed genes (Figure 3B), sug-
gesting a minimal effect of ATF3 on the pancreatic response to 
cerulein. Because very few genes were seen to be differentially ex-
pressed at an adjusted p < 0.01 (chosen due to the higher variability 
between cerulein and saline conditions), we reduced the stringency 
of our analysis to a nonadjusted p < 0.01 to encompass more poten-
tially relevant genes. This direct comparison between ATF3 CIP ver-
sus WT CIP samples identified 274 genes that require ATF3 for ap-
propriate changes in expression (Figure 3D and Supplemental Table 
S10). These genes could be clustered into four distinct groups: 
genes increased or decreased in only WT tissue, and genes in-
creased or decreased in only Atf3–/– tissue. Several genes linked to 
the UPR (including Ddit3, Hsp5a, and Fgf21) showed higher expres-
sion in the absence of ATF3 after CIP, indicating that ATF3 may sup-
press or limit this pathway. Conversely, a number of genes linked to 
acinar cell differentiation, including Sox9 and Krt19, were increased 
in only WT mice during CIP. These findings support a role for ATF3 
in affecting acinar cell differentiation.
In support of a role for ATF3 in affecting acinar cell differentiation 
during CIP, ChIP-seq of WT pancreatic tissue revealed ATF3 enrich-
ment at both acinar cell maturity (Nr5a2, Mist1) and progenitor 
(Sox9, Rbpj) marker genes (Figure 4A and Supplemental Figure S7B; 
data not shown for Rbpj). Thus we compared the expression of 
both between WT and Atf3–/– tissue during CIP (Figure 4A). Com-
parison of gene expression by quantitative reverse transcription-
PCR (qRT-PCR) showed a significant decrease in Nr5a2 expression in 
WT tissue 4 h into CIP (Figure 4A), which did not reach significance 
in Atf3–/– mice, although a distinct trend was observed. In agree-
ment with the RNA-seq data, significant differences in Sox9 were 
observed only in WT tissue (Figure 4A), suggesting that ATF3 is re-
quired for up-regulation of factors that promote acinar cell dedif-
ferentiation. Examination of other markers of ADM identified a 
similar increase in Krt19 (Figure 4B), but not Pdx1 (Supplemental 
Figure S5A), only in WT tissue. By 72 h into CIP, a time consistent 
decreased) was identified for where ATF3 enrichment occurred or 
the type of consensus sites found within the ATF3 enrichment site 
(unpublished data).
GO overexpression analysis on the 1203 ATF3 genes that are 
differentially expressed 4 h into CIP treatment identified 146 path-
ways with greater than twofold enrichment (based on p < 0.01; 
Supplemental Table S4). This suggests a widespread effect of ATF3 
on acinar cell function in response to CIP. Pathway analysis via 
PANTHER/KEGG analysis (Supplemental Tables S5 and S6) again 
identified pathways linked to the UPR, cell organization, cerulein 
treatment (CCK and MAPK signaling), and pathways involved in af-
fecting pancreatitis severity, such as oxidative stress (Sah et al., 
2014) and platelet-derived growth factor signaling (Aghdassi et al., 
2011), or implicated in acinar-to–duct cell metaplasia (RAS (Logsdon 
and Lu, 2016), EGF (Ardito et al., 2012), and Wnt signaling (Morris 
et al., 2010)).
To determine the expression changes that are dependent on 
ATF3 during CIP, we compared changes in pancreatic mRNA accu-
mulation between WT and Atf3–/– mice after 4 h of cerulein treat-
ment (Figure 3). Sample-to-sample distance clustering showed a 
distinct segregation of RNA expression patterns based on saline 
versus cerulein treatment (Figure 3A). Saline-treated Atf3–/– pancre-
atic tissue showed no significant differences in gene expression 
compared with saline-treated WT tissue (adjusted p < 0.01; Figure 
3B), suggesting that ATF3 has little contribution to the normal physi-
ology and function of the pancreas. This finding is expected be-
cause ATF3 is not expressed under conditions of normal pancreatic 
homeostasis. After CIP treatment, the expression of 3482 genes 
(adjusted p < 0.01) was significantly altered in WT pancreatic tissue 
relative to saline-treated tissue (Table 1 and Figure 3B). Of these 
3482 genes, only 2189 (62.9%) were also differentially expressed 
between saline- and CIP-treated Atf3–/– tissues. An additional 432 
A. Changes in gene expression during CIP related to ATF3 
enrichment
ChIPa
(+) RNASeq 
WTb
(+) RNAseq 
Atf3–/–b
Peaks 12,535 
Peaks ± 5 kb 5759 (3411) 1203 959
Peaks ± 25 kb 10,556 (6116)
Common (± 5 kb) 860 860
Unique WT 343
Unique Atf3–/– 99
B. Changes in gene expression during CIP
Genotype Total change
Increased 
expression
Decreased 
expression
WT 3482 2263 1219
Atf3–/– 2621 1702 919
Common 2189 1482 707
Unique to WT 1293 781 512
Unique to Atf3–/– 432 220 212
aATF3 enrichment peaks were called using MACS2 with a cutoff p of 0.0001.
bRNA-seq gene expression changes were derived with the DESeq2 and an 
adjusted p value of 0.01.
TABLE 1: ChIP-seq and RNA-seq comparisons of WT and Atf3–/– 
response to CIP.
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with pancreatic regeneration, both Sox9 
(Figure 4C) and Pdx1 (Supplemental Figure 
S5B) expression are increased only in WT 
mice, whereas Nr5a2 showed no difference 
in expression between saline- and CIP-
treated tissue from either genotype. We 
next assessed Rbpj and Rbpjl, which are co-
factors for Ptf1a and are expressed in pro-
genitor and mature acinar cells, respectively 
(Masui et al., 2010). Rbpj and Rbpjl were 
quantified relative to Mrpl, an internal con-
trol gene that does not change during pan-
creatitis, and then presented as a ratio of 
Rbpj to Rbpjl. The ratio of Rbpj to Rbpjl, in-
dicating a switch from mature to progenitor 
cells, was significantly increased 4 h into CIP 
for both genotypes but only in WT mice 
72 h after initiating CIP (Figure 4D), support-
ing a requirement for ATF3 in promoting 
acinar cell dedifferentiation.
During pancreatitis, acinar cell dediffer-
entiation involves down-regulation of fac-
tors that promote a mature acinar cell phe-
notype, including the transcription factor 
MIST1 (Karki et al., 2015). We previously 
showed that MIST1 is required for complete 
acinar cell maturation (Pin et al., 2001), and 
others showed the requirement for Mist1 
repression during ADM after CIP (Karki 
et al., 2015). To determine whether ATF3 
plays a role in regulating MIST1 expression, 
we examined the expression of MIST1 in WT 
and Atf3–/– tissue after CIP. IF analysis (Figure 
4E) confirmed MIST1 protein accumulation 
in WT tissue is lost 4 h into cerulein treat-
ment and is present at lower levels at 8 h 
after initial cerulein injection (Supplemental 
Figure S6). Similar analysis in Atf3–/– tissue 
showed maintained MIST1 accumulation at 
both time points (Figure 4E and Supple-
mental Figure S6), suggesting that ATF3 is 
required for reduced MIST1 accumulation 
observed during CIP (Karki et al., 2015). Fur-
ther confirmation for a role of ATF3 in reduc-
ing MIST1 accumulation was observed 
through IF analysis of serial sections from 
pancreatic tissue 28 d after cessation of re-
current CIP treatment. These data showed 
limited MIST1 accumulation where pockets 
of ATF3 expression were maintained (Figure 
4F), indicating a prolonged role for ATF3 in 
repressing Mist1 expression after CIP.
To illustrate a direct transcriptional role 
for ATF3 in CIP, we next examined ATF3’s 
ability to directly regulate the Mist1 gene. 
Mist1 is an attractive target for further 
analysis since CIP leads to decreased cell 
differentiation, and MIST1 is an overall reg-
ulator of the mature acinar cell phenotype 
(Pin et al., 2001). Both ChIP-seq and tar-
geted ChIP-PCR confirmed increased ATF3 
FIGURE 2: ChIP-seq analysis for ATF3 targets 4 h into CIP. (A) Annotation of all called peaks 
(12,535) for ATF3 ChIP-seq at 4 h into cerulein treatment compared with 12,535 random 
locations. (B) Heat map showing ATF3 enrichment (input subtracted) at all mm10 RefSeq genes. 
ATF3 is generally localized near the TSSs (TES, transcriptional end site). (C) Motif analysis 
identifying consensus sequences found in peaks located within 5 kb of a TSS, along with the 
percentage of peaks in which these motifs appear and the potential proteins that bind these 
motifs. (D) Gene expression analysis of pancreatic tissue treated for 4 h with saline (SAL) or 
cerulein (CIP), showing increased (yellow) or decreased (blue) expression was cross-referenced 
to ChIP-seq analysis showing ATF3 enrichment. Numbers indicate the total number of genes in 
each group, with the percentage in brackets reflecting the proportion of ATF3-enriched genes 
that increase or decrease.
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enrichment, which is expected given the 
negligible level of ATF3 accumulation in the 
absence of CIP. Examination of the se-
quence 2500 base pairs upstream of the 
Mist1 TSS identified two putative ATF3-
binding sites that are conserved across mul-
tiple species (Supplemental Figure S7).
ATF3 is known to repress genes through 
multiple mechanisms, including the recruit-
ment of repressive histone deacetylases 
(HDACs) to gene promoters (Li et al., 2010; 
Zhao et al., 2016). ATF3 recruitment of 
HDAC1 underlies inhibition of inflammatory 
gene transcription (Gilchrist et al., 2006; Li 
et al., 2010), and ATF3 can act as a corepres-
sor in conjunction with HDAC6 (Li et al., 
2016). Several HDACs are expressed in pan-
creatic tissue, and our previous microarray 
data suggested that HDAC5 might be spe-
cifically increased in pancreatic tissue in re-
sponse to CIP (Kowalik et al., 2007). It is pos-
sible that ATF3 recruits HDACs to the Mist1 
gene after CIP. In support of this theory, 
ChIP–quantitative PCR (qPCR) for acetylated 
H3 showed decreased enrichment of acety-
lated H3 across the Mist1 promoter after CIP 
treatment, suggesting ATF3 represses Mist1 
expression through histone deacetylation 
(Figure 5B). To determine which HDACs may 
contribute to ATF3-mediated repression, we 
examined the accumulation of several 
HDACs during CIP treatment. IF analysis 4 h 
into CIP showed consistent increases in nu-
clear accumulation for HDAC5 (Figure 5C) 
and decreased HDAC3 accumulation (un-
published data), with HDAC1 accumulating 
to a similar extent in both saline- and ceru-
lein-treated mice (Figure 5C). ChIP analysis 
for HDAC5 revealed enhanced enrichment 
at the ATF3-binding site within the Mist1 pro-
moter only in CIP-treated chromatin samples, 
whereas ChIP for HDAC1 showed no enrich-
ment (Figure 5D). HDAC5 recruitment was 
dependent on ATF3, as no such recruitment 
was observed in Atf3–/– tissue (Figure 5E).
Altering genes that affect ADM in Atf3–/– 
acinar cells is consistent with the ChIP-seq 
and RNA-seq analyses, which suggested 
involvement of ATF3 in regulating genes in-
volved in cell–cell interactions (adherens 
junctions, tight junctions, etc.). Loss of the 
mature acinar phenotype, including disrup-
tion of cell junctions, is an early event in the 
progression of pancreatitis (Shi et al., 2013). 
Therefore we examined accumulation of 
cell junctional complexes as an indicator of 
acinar cell maturity (Figure 6). IF for markers 
of tight junctions (ZO-1), adherens junctions 
(β-catenin), and gap junctions (Cx32) all showed a reduction in ac-
cumulation within 4 h of initial cerulein injections in WT mice (Figure 
6A), consistent with previous studies (Lerch et al, 1997; Frossard 
et al, 2003; Schmitt et al, 2004). Conversely, Atf3–/– acinar cells 
enrichment upstream of the Mist1 TSS, suggesting that ATF3 di-
rectly targets Mist1 early in CIP. ATF3 enrichment was consistently 
observed ∼2500 base pairs upstream of the Mist1 TSS 4 h into CIP 
treatment (Figure 5A), whereas saline-treated tissue showed no such 
FIGURE 3: Lack of ATF3 alters the molecular response to CIP. (A) Distance correlation heat map 
comparing global gene expression in male WT and Atf3–/– mice treated with saline (SAL; n = 2) 
or cerulein (CIP; n = 3). (B) MA plots for global gene expression of the four different conditions 
in the RNA-seq; significantly differentially expressed genes (p-adj < 0.01) are indicated in red. 
Number of differentially expressed genes is indicated in the top right. (C) Heat maps comparing 
gene expression differences between WT and Atf3–/– pancreatic tissue 4 h into saline or cerulein 
treatment identified seven ill-defined gene clusters based on similar changes in expression 
(indicated in black and white). (D) Heat maps of genes determined as differentially expressed 
between WT and Atf3–/– cerulein-treated pancreatic tissue (p < 0.01) identified 274 genes 
grouped into four clusters based on expression changes, including those that increased only in 
Atf3–/– (red) or WT tissue (yellow), or decreased only in Atf3–/– (green) or WT tissue (blue) See 
Supplemental Table S10 for gene lists.
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revealed maintained accumulation only in Atf3–/– tissue during CIP 
(Figure 6B). Cell–cell junction organization and cell junction assem-
bly were identified in our GO analysis as targets of ATF3 regulation 
(Supplemental Table S2). Whereas ChIP-seq showed enrichment for 
maintained accumulation of these junctional markers 4 h (Figure 
6A) into CIP, suggesting that the mature acinar cell phenotype is 
maintained in these animals. IF analysis for atypical PKCζ, a marker 
of cell polarity that regulates junctional formation (Storz, 2015), also 
FIGURE 4: Atf3–/– mice show maintained expression of differentiation factors during CIP. (A) qRT-PCR analysis and 
ChIP- and RNA-sequencing gene tracks for Nr5a2 or Sox9 4 h into saline (SAL) or cerulein (CIP) treatment in wild-type 
(WT; n = 4 [SAL] or 5 [CIP]) and Atf3–/– tissue (n = 6; *p < 0.05; **p < 0.01). Called peaks of ATF3 enrichment are marked 
by asterisks. Similar qRT-PCR analysis for Krt19 at 4 h (B) or Sox9 and Nr5a2 at 72 h (C) after initiating CIP. n = 4 or 5; 
*p < 0.05. (D) Ratio of Rbpj:Rbpjl (relative to Mrpl) based on qRT-PCR analysis 4 or 72 h after initiating CIP. Letters 
indicate statistically different values (n = 4 or 5; p < 0.05). (E) Representative immunofluorescence analysis for MIST1 in 
saline or CIP-treated wild type (WT) and Atf3–/– mice 4 h into cerulein treatment show maintained MIST1 expression only 
in Atf3–/– tissue. Bar, 20 μm. (F) Representative IF for MIST1 or ATF3 on serial sections from pancreatic tissue 28 d after 
chronic CIP injections. Pockets of ATF3-positive/MIST1-negative cells are outlines by the dotted line. Cell nuclei are 
stained by DAPI. Bars, 70 μm.
2354 | E. N. Fazio et al. Molecular Biology of the Cell
areas of regeneration, characterized by fi-
brosis, inflammation (Figure 7, D and E), and 
ADM based on histology and SOX9 IHC 
(Figure 7F). Combined, these results suggest 
that ATF3 protects against pancreatic injury 
by, in part, targeting Mist1 for repression by 
HDACs, thereby leading to loss of the ma-
ture acinar cell phenotype.
DISCUSSION
During pancreatic injury, the acinar cell dif-
ferentiation program is repressed, with cells 
taking on a more progenitor-like state in an 
effort to reduce the amount of tissue dam-
age associated with injury. Whereas several 
studies highlighted the importance of acinar 
cell maturation factors in reducing ADM 
(von Figura et al., 2014; Karki et al., 2015; 
Martinelli et al., 2015), it is unclear how 
these factors are repressed during acute 
pancreatic injury. In this study, we identified 
ATF3 as an important mediator of gene ex-
pression early in CIP, including repressing 
the differentiated acinar molecular profile. 
The absence of ATF3 is correlated with 
maintained expression of differentiated aci-
nar cell gene expression and increased pan-
creatic damage during early injury. During 
tissue regeneration, lack of ATF3 results in 
decreased expression of ADM-promoting 
factors and a resultant reduction of ADM. 
On a mechanistic level, ATF3 was enriched 
at multiple genes that either promote or re-
press acinar cell differentiation and was re-
quired for recruiting HDAC5 to the Mist1 
gene, illustrating a direct role for ATF3 in 
regulating the acinar cell phenotype.
Previous work by several laboratories has shown a rapid onset 
of ATF3 expression in the pancreas after injury (Hartman et al., 
2004; Jiang et al., 2004), likely as part of the UPR/ER stress re-
sponse pathway. The UPR has a physiological role in the pancreas, 
likely due to the high level of protein production within acinar 
cells. Deletion of Perk, Ire1, or Xbp1 has significant consequences 
on pancreatic tissue (Zhang et al., 2002; Iida et al., 2007; Iwawaki 
et al., 2010; Hess et al., 2011). However, unlike other key media-
tors of the UPR in the pancreas, ATF3 expression is limited to 
injured tissue, and the loss of Atf3 has no observable effect on 
pancreatic biology or gene expression in the absence of injury. 
This suggests that ATF3 may distinguish UPR functions between 
normal acinar cell physiology (maintenance of protein-folding 
capacity) and pathology (general repression of protein translation 
and alterations in gene transcription).
One of the earliest responses to experimental models of pancre-
atitis is the rapid repression of the acinar differentiation program. 
Repression of the acinar cell phenotype through decreased expres-
sion of acinar differentiation factors (Mist1, Rbpjl, Nr5a2) helps re-
duce tissue damage (Masui et al., 2010; von Figura et al., 2014). We 
showed a clear role for ATF3 in repression of the acinar phenotype 
through enrichment of ATF3 at the promoters of the foregoing 
genes 4 h after injury and, in the case of Mist1, a role for ATF3 in the 
recruitment of repressive HDACs to the gene. Furthermore, loss of 
ATF3 expression is correlated to maintained MIST1 expression, and 
ATF3 at genes encoding Cx32 and ZO-1 (unpublished data), the 
genes encoding ZO-1, β-catenin, and Cx32 were not significantly 
reduced during CIP based on RNA-seq data. This suggests that ei-
ther factors involved in stabilization or targeting of ZO-1, β-catenin, 
and Cx32 are affected by ATF3 or changes in gene expression occur 
at later time than 4 h after CIP. However, loss of accumulation for 
ZO-1, β-catenin, and Cx32 is consistent with previous work and sug-
gests that multiple mechanisms exist to reduce protein levels.
Acinar cell dedifferentiation is believed to be an important step in 
limiting damage to pancreatic injury. Therefore, on the basis of the 
foregoing findings, we predicted that Atf3–/– mice would show in-
creased damage to CIP treatment as they maintain the differentiated 
acinar cell phenotype during injury. Examination of CIP severity 
through histological analysis confirmed that Atf3–/– mice are more 
sensitive to cerulein treatment. At both 4 h (Figure 7A) and 8 h 
(Figure 7B) into cerulein treatment, Atf3–/– mice showed a markedly 
worse response to CIP, with increased necrosis and edema readily 
observed relative to WT mice (unpublished data). Histological grad-
ing confirmed increased leukocyte infiltration at these time points, 
and qRT-PCR revealed increased levels of the proinflammatory cyto-
kine interleukin 6 in Atf3–/– animals (Supplemental Figure S8). Ele-
vated serum amylase levels were also observed in Atf3–/– mice 8 h 
into treatment, consistent with increased tissue damage (Figure 7C). 
However, histological analysis revealed dramatically different results 
72 h into CIP treatment, when WT tissue showed significantly more 
FIGURE 5: ATF3 represses Mist1 expression in part through recruitment of HDAC5. (A) ChIP-
qPCR for ATF3 enrichment along the Mist1 gene shows enrichment specifically at region II (–2500 
base pairs relative to the Mist1 TSS) only after induction of CIP (4 h). Representative ChIP-PCR 
shows ATF3 enrichment at the Mist1 promoter. (B) ChIP-PCR and ChIP-qPCR reveals decreased 
acetylated H3 (Ac-H3) at the Mist1 promoter 4 h into CIP. Two different saline and CIP samples 
are shown for ChIP-PCR. (C) IF shows increased nuclear accumulation of HDAC5 at 4 h into CIP 
(arrows) with no change in HDAC1 accumulation. Bar, 70 μm. (D) ChIP-qPCR for HDAC5 shows 
enrichment ∼2.5 kb upstream of the Mist1 TSS only after 4 h of CIP treatment. (E) HDAC5 
requires ATF3 for recruitment to the Mist1 gene (A–/– = Atf3–/–). *p < 0.05, n = 3 in all cases.
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phenotype by inhibiting both PDX1 expres-
sion and activity (Jang, 2011; Kim et al., 
2011), and our ChIP-seq data showed enrich-
ment of ATF3 at the Pdx1 gene (unpublished 
data). However, this enrichment did not 
correlate with decreased Pdx1 expression, 
suggesting that ATF3 may be involved in tar-
geting transcriptional complexes to the ge-
nome but has different effects based on the 
transcriptional complex to which it is associ-
ated. Whereas ATF3 interacts with a variety 
of transcription factors and recruits multiple 
HDACs (this study; Li et al., 2010; Zhao et al., 
2016), it can also interact with NFκB (Kwon 
et al., 2015), CEBP (Jang et al., 2012), PDX1 
(Jang, 2011), and other bZIP transcription 
factors (Thompson et al., 2009). This promis-
cuity suggests a multifaceted role for ATF3 in 
the transcriptional profile of the cell. Our 
findings that ATF3 is enriched within 5 kb of 
>30% of all the genes that show greater than 
twofold increase in expression indicates that 
ATF3 is a crucial mediator of gene transcrip-
tion during injury, affecting multiple cellular 
pathways in addition to its effects on acinar 
cell differentiation.
Although loss of the acinar cell pheno-
type may initially be protective, ATF3-medi-
ated ADM could promote development of 
PDAC because enhanced ADM leads to 
increased sensitivity to oncogenic KRAS in-
duction of PDAC (Logsdon and Ji, 2009; 
Krah et al., 2011; Shi et al., 2013). Com-
bined with the knowledge that maintained 
expression of MIST1 prevents KRAS-driven 
PanIN formation (Shi, 2009), we postulate 
that ATF3-mediated repression of Mist1 
may promote susceptibility to PDAC. Analysis of our RNA-seq data 
indicates loss of ATF3 affects many cancer initiating pathways, in-
cluding EGF receptor signaling, MAPK signaling, and the Ras path-
way. Therefore repression of ATF3 during pancreatitis may reduce 
ADM and decrease susceptibility to PDAC. We are generating Atf3–/– 
mice in an oncogenic KRAS background to test this possibility.
In conclusion, we identified ATF3 as an important transcriptional 
regulator of pancreatic acinar cells during the response to cerulein-
induced pancreatic injury. Our data show that ATF3 regulates mul-
tiple gene networks and cellular functions, including a primary role 
in promoting the loss of the acinar cell phenotype through activat-
ing and repressive transcriptional mechanisms. Specifically, we show 
that ATF3 is required for HDAC recruitment to repress transcription 
at the promoter for the acinar cell maturation factor, MIST1. 
Although promoting a more progenitor-like cell phenotype in re-
sponse to injury will limit the amount of tissue damage, it is unclear 
whether long-term activation of ATF3 will allow for a greater sensi-
tivity to factors that promote PDAC.
MATERIALS AND METHODS
Animals and induction of cerulein-induced pancreatitis
Mouse experiments followed guidelines in protocol 2008-116 ap-
proved by the Animal Care and Use Committee at the University of 
Western Ontario. Pancreatitis was induced in 2- to 4-mo-old C57Bl6 
mice and congenic mice containing homozygous deletion of Atf3 
stabilization of the differentiated acinar cell profile evidenced with 
maintenance of junctional complexes (ZO-1, β catenin, and Cx32) 
and polarity markers (PKCζ). We show that the maintenance of 
these factors is correlated with increased damage at early time 
points in the pancreatitis response, which is consistent with previous 
findings that maintained MIST1 was correlated with increased sever-
ity of CIP (Karki et al., 2015). Surprisingly, none of these genes 
(Mist1, Cx32, ZO1, and β catenin) was identified by RNA-seq to be 
significantly decreased in either wild-type or Atf3–/– mice during CIP. 
However, all of these factors have been identified as repressed by 
previous studies (Lerch et al., 1997; Frossard et al., 2003; Schmitt 
et al., 2004; Karki et al., 2015), and each showed a trend toward re-
pression in WT tissue (unpublished data). Therefore we suggest 
that the differences are likely due to the short time after induction of 
injury that we examined RNA expression (4 h) compared with these 
other studies and indicate that multiple transcriptional and post-
translational mechanisms (i.e., protein degradation) may combine to 
regulate the expression of these factors.
Conversely, ATF3 was also enriched at the promoters of genes 
that promote acinar cell dedifferentiation, including Sox9, Pdx, and 
Rbpj, which are all increased in expression during pancreatic injury. 
Furthermore, Atf3–/– tissue shows reduced expression of these factors 
during injury, illustrating that ATF3 activates and represses genes 
regulating the ADM process during CIP. Previous work in pancreatic 
β-cells showed that ATF3 promotes loss of the mature β-cell 
FIGURE 6: Atf3–/– acinar cells maintain cell junction complexes during CIP. IF for markers of 
(A) adherens junctions (β-catenin), tight junctions (ZO-1), and gap junctions (Cx32) or (B) cell 
polarity (PKCζ). Expression and localization is maintained in Atf3–/– acini 4 h into CIP 
treatment, contrasting the loss of accumulation observed in CIP-treated WT mice. Individual 
acini are delineated by a dashed line and Cx32 plaques indicated by arrows. Bar, 14 μm.
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Imaging System with Quantity One 1-D Anal-
ysis software (Bio-Rad).
RNA isolation, qRT-PCR, and RNA-seq
RNA was isolated from mouse pancreatic 
tissue using TRIZOL (Invitrogen, Carlsbad, 
CA) as previously described (Johnson et al., 
2009). cDNA was synthesized using Im-
PromII Reverse transcriptase (Sigma-
Aldrich). PCR was carried out using GoTaq 
flexi DNA polymerase (Sigma-Aldrich) and 
gene-specific primer sequences (Supple-
mental Table S1). qRT-PCR was carried out 
using the GoTaq PCR Mastermix system 
(Promega, Madison, WI) using an ABI Prism 
7900HT Sequence Detection System and 
corresponding SDS 2.2.1 software (Applied 
Biosystems, Foster City, CA). The quality 
and quantity of RNA samples were assessed 
using an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Santa Clara, CA). Total RNA 
was used to construct a stranded, rRNA-de-
pleted RNA library, followed by next gener-
ation sequencing using the Illumina HiSeq 
2500 with 100–base pair paired-end reads 
(Centre for Applied Genomics, Toronto, 
Canada). The complete RNA-seq data can 
be found at Gene Expression Omnibus 
(GEO) accession (pending).
RNA-seq reads were aligned to the 
mouse mm10 genome (mm10_v6) with Gen-
code M9 annotations using STARv2.4.2a 
(Dobin et al., 2013); notable options included 
–outFilterScoreMinOverLread 0.55, –outFil-
terMatchNminOverLread 0.55. STARv2.4.2a 
was also used to generate .wig files for visu-
alization in the UCSC Genome Browser. 
Aligned reads were sorted with samtools (Li 
et al., 2009; Li, 2011), and gene counts were 
done with HTSeq (Anders et al., 2015) using 
the htseq-count function and Gencode M9 
annotations. Differential expression analysis 
was derived with the DESeq2 (Love et al., 
2014) package. All differential expression 
data used for downstream analysis were cut off at an adjusted p value 
of 0.01 (p-adj < 0.01). GO (Ashburner et al., 2000; The Gene Ontol-
ogy Consortium, 2015) terms and pathways were derived via PAN-
THER (Thomas et al., 2003; Mi and Thomas, 2009; Mi et al., 2017), 
whereas KEGG pathways were derived from DAVID (Huang et al., 
2009a,b).
ChIP PCR, ChIP-seq, and bioinformatics analysis
Chromatin was isolated from pancreatic tissue of mice treated for 
4 h with cerulein as described (Fazio et al., 2011; Mehmood et al., 
2014). Purified antibodies against ATF3 (1:500, Santa Cruz Biotech-
nology), HDAC1 (1/250; Active Motif, Carlsbad, CA), HDAC5 (Cell 
Signaling Technology), and acetylated H3 (Millipore, Etobicoke, 
Canada) were used for ChIP and qPCR performed using the GoTaq 
PCR Mastermix system. Average Ct values for individual ChIP and 
immunoglobulin G controls were expressed as a percentage of 
starting chromatin samples (input). ATF3 ChIP was followed by next-
generation sequencing (ChIP-seq). Chromatin was pooled from 
(Atf3–/–; Hartman et al., 2004). Atf3–/– mice were kindly provided by 
Tsonwin Hai, The Ohio State University. Mice were given up to eight 
hourly intraperitoneal injections of cerulein (Sigma-Aldrich, St. Louis, 
MO; 50 µg/kg of body weight), a cholecystokinin analogue, to in-
duce mild edematous, acute pancreatitis, as previously described 
(Johnson et al., 2009). Animals were killed 1–72 h after initiation of 
pancreatitis. Blood was obtained through cardiac puncture for as-
sessment of serum amylase as described (Kowalik et al., 2007).
Protein isolation and Western blotting
Pancreatic protein was isolated as described (Kowalik et al., 2007) and 
quantified using a Bio-Rad protein assay (Bio-Rad, Hercules, CA). 
Isolated protein was resolved by SDS–PAGE and transferred to poly-
vinylidene fluoride membrane (Bio-Rad). Western blot analysis was 
carried out as described (Fazio et al., 2011) using antibodies specific 
for ATF3 (Santa Cruz Biotechnology, Dallas, TX), sXBP1 (BioLegend, 
San Diego, CA), MIST1 (Pin et al, 2000), and total ERK (Cell Signaling 
Technology, Danvers, MA). Blots were visualized using the VersaDoc 
FIGURE 7: Atf3–/– mice show a differential response to cerulein-induced pancreatitis. H&E 
histology at 4 h (A) and 8 h (B) into CIP support more damage in the Atf3–/– pancreas based on 
increased inflammatory cells, necrosis, and apoptosis. Bars, 160 μm (white), 25 μm (black). 
(C) Serum amylase levels show increased levels in both WT and Atf3–/– tissue 4 and 8 h after 
initial cerulein treatment; *, p < 0.05 relative to WT saline; **, p < 0.01 relative to WT saline; 
†, p < 0.05 relative to WT CIP. Representative H&E histology 72 h into CIP (D) shows more 
damage in the presence of ATF3, as quantified by significantly increased lesion area (E). Bars, 
167 μm (small), 150 μm (large). p value represents a two-tailed unpaired t test. (F) Representative 
IHC images for SOX9 expression show increased SOX9 accumulation in WT tissue relative to 
Atf3–/– pancreatic tissue. Bars, 100 μm.
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whole pancreatic tissue of three mice, and ChIP was carried out as 
described (Fazio et al., 2011; Mehmood et al., 2014). Enriched 
pooled DNA fragments from ChIP reactions from three biological 
replicates per group were sequenced using the Illumina 2.0 genome 
analyzer (Beijing Genomics Institute, Hong Kong). The complete 
ChIP-seq data can be found at GEO accession GSE60250.
ChIP-seq reads were aligned to mouse genome mm10 using 
Bowtie2 (Langmead and Salzberg, 2012) with default settings. Peaks 
were called using MACS2 (Zhang et al., 2008) with p = 0.0001. Cus-
tom Perl scripts were used to generate .wig files for visualization in 
the UCSC Genome Browser and to annotate peaks with gene 
features using Gencode M9 annotations. Heat maps and density 
profiles were made using deepTools (Ramirez et al., 2014). Random 
positions were generated using Bedtools shuffle (Quinlan and Hall, 
2010). DNA sequence motifs were identified using MEME-ChIP 
(Machanick and Bailey, 2011) with the -nmeme option increased 
to 5000: motifs were discovered using MEME and then passed to 
Centrimo to identify centrally enriched motifs and to TOMTOM to 
identify putative binding proteins from the Jaspar Core (2016) verte-
brate database (Mathelier et al., 2016).
Histological analysis and serum amylase assay
Mouse pancreata were immediately frozen in cryomatrix and sec-
tioned at 6 µm. Cryostat sections were processed for IF as described 
(Fazio et al., 2005). For paraffin expression, mouse pancreata were 
fixed in 4% Formalin overnight at 4°C and washed with phosphate-
buffered saline several times before paraffin embedding, followed 
by sectioning at 5 µm.
Paraffin sections of mouse pancreatic tissue were stained with 
hematoxylin and eosin (H&E) and imaged using light microscopy. 
Sections from WT and Atf3–/– mice 72 h after initiation of CIP were 
assayed for the presence of lesions and ADM. Total lesion area was 
calculated as a percentage of the total pancreatic tissue area. For 
both lesion and ADM analysis, three different sections were assayed 
from each individual pancreas to produce an average value. Primary 
antibodies used for IF included those specific for MIST1 (1:500), 
ATF3 (1:500), β-catenin (1:2000; Sigma-Aldrich), ZO-1 (1:100; 
Chemicon, Temecula, CA), Cx32 (1:100; Chemicon), PKCζ (1/500; 
Sigma-Aldrich), HDAC1 (1/250; Active Motif), HDAC3 (1:500; 
Abcam, Cambridge, MA), and HDAC5 (1/250; Cell Signaling Tech-
nology), and SOX9 expression (1:500; Abcam) was determined 
by IHC. Secondary antibodies included anti-mouse fluorescein 
isothiocyanate (FITC) and anti-rabbit FITC (1:250, Jackson Immu-
noResearch, West Grove, PA). Tissue sections were counterstained 
with eosin upon completion of immunohistochemical staining or 
4′,6-diamidino-2-phenylindole (DAPI) after IF.
Statistical analysis
Differences between experimental groups were analyzed using two-
way analysis of variance, followed by a Bonferroni post hoc test. All 
qRT-PCR results were analyzed using unpaired t tests, with the 
exception of the Rbpj and Rbpjl comparisons. Significance is consid-
ered as p < 0.05.
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